Clever Leaves Holdings Stock Price, News & Analysis
Company Description
Clever Leaves Holdings (OTC Link: CLVRW) is a publicly traded drug manufacturers - specialty & generic company in the Pharmaceutical Preparations sector.
CLVRW stock has gained 0.0% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of CLVRW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Clever Leaves Holdings (CLVRW) stock last traded at $0.0001.
Latest News
Clever Leaves Holdings has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, conferences, stock split. View all CLVRW news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Clever Leaves Holdings (CLVRW) currently stands at 1.7 thousand shares, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Clever Leaves Holdings (CLVRW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
CLVRW Company Profile & Sector Positioning
Clever Leaves Holdings (CLVRW) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Pharmaceutical Preparations sector and is listed on the OTC Link.
Investors comparing CLVRW often look at related companies in the same sector, including Biofrontera (BFRIW), Im Cannabis Corp (IMCC), China Pharma (CPHI), Sunshine Biopharma Inc (SBFMW), and Flora Growth Corp (FLGC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLVRW's relative position within its industry.